345 related articles for article (PubMed ID: 25936625)
1. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
[TBL] [Abstract][Full Text] [Related]
2. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
[TBL] [Abstract][Full Text] [Related]
3. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Taghdisi SM; Lavaee P; Ramezani M; Abnous K
Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Taghdisi SM; Abnous K; Mosaffa F; Behravan J
J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
[TBL] [Abstract][Full Text] [Related]
5. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
7. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
[TBL] [Abstract][Full Text] [Related]
9. Identification and imaging of leukemia cells using dual-aptamer-functionalized graphene oxide complex.
Bahreyni A; Yazdian-Robati R; Ramezani M; Rasouli M; Alinezhad Nameghi M; Alibolandi M; Abnous K; Taghdisi SM
J Biomater Appl; 2017 Jul; 32(1):74-81. PubMed ID: 28549385
[TBL] [Abstract][Full Text] [Related]
10. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
[TBL] [Abstract][Full Text] [Related]
11. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
12. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination.
Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789
[TBL] [Abstract][Full Text] [Related]
13. DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy.
Sadeghi M; Koushki K; Mashayekhi K; Ayati SH; Keshavarz Shahbaz S; Moghadam M; Sankian M
Int Immunopharmacol; 2020 Sep; 86():106690. PubMed ID: 32585607
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation.
Guo D; Wu C; Jiang H; Li Q; Wang X; Chen B
J Photochem Photobiol B; 2008 Dec; 93(3):119-26. PubMed ID: 18774727
[TBL] [Abstract][Full Text] [Related]
15. Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo.
Yazdian-Robati R; Ramezani M; Jalalian SH; Abnous K; Taghdisi SM
Pharm Res; 2016 Sep; 33(9):2289-97. PubMed ID: 27283831
[TBL] [Abstract][Full Text] [Related]
16. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
18. Biomedical Applications of DNA-Conjugated Gold Nanoparticles.
Wang CC; Wu SM; Li HW; Chang HT
Chembiochem; 2016 Jun; 17(12):1052-62. PubMed ID: 26864481
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy.
Li T; Zhang M; Wang J; Wang T; Yao Y; Zhang X; Zhang C; Zhang N
AAPS J; 2016 Jan; 18(1):146-55. PubMed ID: 26381779
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticle-DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins.
Ryou SM; Yeom JH; Kang HJ; Won M; Kim JS; Lee B; Seong MJ; Ha NC; Bae J; Lee K
J Control Release; 2014 Dec; 196():287-94. PubMed ID: 25450403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
